Get the Stockscreener App
31.20
1.84%
0.565
After Hours:
31.20
Why is Akero Therapeutics Inc (AKRO) Stock down?
We've noticed a 5.61% decline in Akero Therapeutics Inc (AKRO) stock during the 2024-11-15 trading session. While this could be attributed to normal volatility or various internal and external factors, please be aware that we are actively monitoring the situation, and we'll provide timely updates as soon as possible!
10 Oct, 2023:
Akero Therapeutics Stock (AKRO) dropped by 62.61% from $48.54 to $18.15 in the trading on Tuesday October 10, 2023. The reason why AKRO stock down today is due to the 36-week analysis of a Phase 2b SYMMETRY study evaluating the efficacy and safety of its lead product candidate efruxifermin (EFX). EFX didn't meet the primary endpoint of the phase 2b study.
0.93%
3.56%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):